RAD001 exhibits strong potential as a therapeutic strategy for ameliorating peripheral poly-neuropathy.
The mechanism underlying the effects of RAD001 in EAN rats involves M2 macrophages polarization.
RAD001 activates p-Akt via inhibiting mTOR pathway, facilitating the phenotype shift of macrophages to M2 type.